Fisler Grace, Izard Stephanie M, Shah Sareen, Lewis Deirdre, Kainth Mundeep K, Hagmann Stefan H F, Belfer Joshua A, Feld Lance M, Mastroianni Fiore, Kvasnovsky Charlotte L, Capone Christine A, Schneider James, Sweberg Todd, Schleien Charles, Taylor Matthew D
Division of Pediatric Critical Care Medicine, Steven and Alexandra Cohen Children's Medical Center of New York, Northwell Health, Donald and Barbara Zucker School of Medicine At Hofstra/Northwell, 269-01 76th Ave, New Hyde Park, NY, 11040, USA.
Department of Pediatrics, Steven and Alexandra Cohen Children's Medical Center of New York, Northwell Health, Donald and Barbara Zucker School of Medicine At Hofstra/Northwell, New Hyde Park, NY, 11040, USA.
Ann Intensive Care. 2020 Dec 19;10(1):171. doi: 10.1186/s13613-020-00790-5.
While much has been reported regarding the clinical course of COVID-19 in children, little is known regarding factors associated with organ dysfunction in pediatric COVID-19. We describe critical illness in pediatric patients with active COVID-19 and identify factors associated with PICU admission and organ dysfunction. This is a retrospective chart review of 77 pediatric patients age 1 day to 21 years admitted to two New York City pediatric hospitals within the Northwell Health system between February 1 and April 24, 2020 with PCR + SARS-CoV-2. Descriptive statistics were used to describe the hospital course and laboratory results and bivariate comparisons were performed on variables to determine differences.
Forty-seven patients (61%) were admitted to the general pediatric floor and thirty (39%) to the PICU. The majority (97%, n = 75) survived to discharge, 1.3% (n = 1) remain admitted, and 1.3% (n = 1) died. Common indications for PICU admission included hypoxia (50%), hemodynamic instability (20%), diabetic ketoacidosis (6.7%), mediastinal mass (6.7%), apnea (6.7%), acute chest syndrome in sickle cell disease (6.7%), and cardiac dysfunction (6.7%). Of PICU patients, 46.7% experienced any significant organ dysfunction (pSOFA > = 2) during admission. Patients aged 12 years or greater were more likely to be admitted to a PICU compared to younger patients (p = 0.015). Presence of an underlying comorbidity was not associated with need for PICU admission (p = 0.227) or organ dysfunction (p = 0.87). Initial white blood cell count (WBC), platelet count, and ferritin were not associated with need for PICU admission. Initial C-reactive protein was associated with both need for PICU admission (p = 0.005) and presence of organ dysfunction (p = 0.001). Initial WBC and presenting thrombocytopenia were associated with organ dysfunction (p = 0.034 and p = 0.003, respectively).
Age over 12 years and initial CRP were associated with need for PICU admission in COVID-19. Organ dysfunction was associated with elevated admission CRP, elevated WBC, and thrombocytopenia. These factors may be useful in determining risk for critical illness and organ dysfunction in pediatric COVID-19.
虽然关于儿童新冠病毒病(COVID-19)的临床病程已有很多报道,但对于儿童COVID-19中与器官功能障碍相关的因素却知之甚少。我们描述了患有活动性COVID-19的儿科患者的危重症情况,并确定了与儿科重症监护病房(PICU)收治及器官功能障碍相关的因素。这是一项对2020年2月1日至4月24日期间在诺斯韦尔医疗系统内两家纽约市儿科医院收治的77例年龄在1天至21岁、聚合酶链反应(PCR)检测SARS-CoV-2呈阳性的儿科患者进行的回顾性病历审查。采用描述性统计来描述住院病程和实验室检查结果,并对变量进行双变量比较以确定差异。
47例患者(61%)入住普通儿科病房,30例(39%)入住PICU。大多数患者(97%,n = 75)存活出院,1.3%(n = 1)仍在住院,1.3%(n = 1)死亡。入住PICU的常见指征包括低氧血症(50%)、血流动力学不稳定(20%)、糖尿病酮症酸中毒(6.7%)、纵隔肿物(6.7%)、呼吸暂停(6.7%)、镰状细胞病急性胸综合征(6.7%)以及心脏功能障碍(6.7%)。在入住PICU的患者中,46.7%在住院期间出现任何显著的器官功能障碍(序贯器官衰竭评估(pSOFA)≥2)。与年龄较小的患者相比,12岁及以上的患者更有可能入住PICU(p = 0.015)。存在基础合并症与入住PICU的需求(p = 0.227)或器官功能障碍(p = 0.87)无关。初始白细胞计数(WBC)、血小板计数和铁蛋白与入住PICU的需求无关。初始C反应蛋白与入住PICU的需求(p = 0.005)和器官功能障碍的存在(p = 0.001)均相关。初始WBC和就诊时的血小板减少与器官功能障碍相关(分别为p = 0.034和p = 0.003)。
12岁以上年龄和初始C反应蛋白与COVID-19患者入住PICU的需求相关。器官功能障碍与入院时C反应蛋白升高、白细胞升高和血小板减少有关。这些因素可能有助于确定儿童COVID-重症和器官功能障碍的风险。